Viewing StudyNCT00082277



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00082277
Status: COMPLETED
Last Update Posted: 2011-01-26
First Post: 2004-05-05

Brief Title: Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
bone loss View
hormone-receptor positive breast cancer View
Osteopenia View
Osteoporosis View
risk of fracture View